Journal articleRes Sq · May 26, 2026
Persistent activation of cardiac fibroblasts into myofibroblasts drives excessive extracellular matrix deposition, leading to maladaptive myocardial fibrosis, adverse remodeling and heart failure (HF) progression. Adipocyte enhancer binding protein 1 (AEBP ...
Full textLink to itemCite
Journal articleThe American journal of cardiology · May 2026
Vericiguat is a soluble guanylate cyclase stimulator previously shown to improve cardiovascular outcomes in patients with heart failure with reduced ejection fraction (HFrEF). However, the underlying mechanisms remain incompletely understood. To evaluate t ...
Full textCite
Preprint · April 26, 2026
ABSTRACTBackgroundMechanical ventricular unloading and systemic circulatory support with left ventricular assist devices (LVADs) enab ...
Full textCite
Journal articleJ Heart Lung Transplant · April 17, 2026
BACKGROUND: Recent reports from UNOS and INTERMACS highlight that left ventricular assist devices (LVADs) remain underutilized as a bridge-to-recovery (BTR) strategy, despite data from registries and other studies demonstrating that a meaningful subset of ...
Full textLink to itemCite
Journal articleJACC. CardioOncology · February 2026
BackgroundThe most common pathogenic transthyretin variant underlying variant transthyretin amyloidosis in the United States is c.424G>A, p.Val142Ile (V142I). In affected individuals, disease manifests predominantly as heart failure (HF) and cardi ...
Full textCite
Journal articleJACC. Basic to translational science · January 2026
Myocardial recovery after left ventricular assist device (LVAD) support is a critical phenomenon that allows advanced heart failure patients to retain their native heart. We quantified targeted sphingolipids in serum and cardiac tissue of patients who exhi ...
Full textCite
Journal articleEuropean heart journal open · January 2026
AimsCardiogenic shock (CS) is the leading cause of in-hospital mortality in patients suffering acute myocardial infarction (AMI). Despite advances in their management, short- and long-term mortality remain unacceptably high. We assessed short and ...
Full textCite
Journal articleCirculation research · January 2026
BackgroundCPT1 (carnitine palmitoyltransferase 1) is a rate-limiting enzyme for long-chain fatty acid oxidation. In adult hearts, CPT1b predominates, while CPT1a is coexpressed at lower levels. Pathological stress on the heart induces CPT1a expres ...
Full textCite
Journal articleJournal of the American Heart Association · December 2025
BackgroundWhether preleft ventricular assist device (LVAD) kidney function relates to myocardial recovery and LVAD-related adverse events remains uncertain. We evaluated the association of baseline estimated glomerular filtration rate (eGFR) with ...
Full textCite
Journal articleEpigenetics · December 2025
Histone H4K20 methylation is critical in regulating the cell cycle, DNA damage response, and gene repression in proliferating cells. However, its role in the heart remains poorly understood. Our previous work revealed that histone H4K20 tri-methylation is ...
Full textCite
Journal articleThe Canadian journal of cardiology · October 2025
BackgroundIn 2019, the Society for Cardiovascular Angiography and Interventions (SCAI) proposed an algorithm to assess cardiogenic shock (CS) severity, known as SCAI classification. In 2022, the Cardiogenic Shock Working Group (CSWG) modified the ...
Full textCite
Journal articleCirculation. Heart failure · July 2025
BackgroundThe left atrium (LA) maintains a dynamic interaction with the left ventricle (LV). LA forward and reverse remodeling affect prognosis in patients with chronic heart failure. We examined LA reverse remodeling in patients supported with LV ...
Full textCite
Journal articleThe Journal of thoracic and cardiovascular surgery · July 2025
BackgroundDonation after circulatory death (DCD) heart transplants have increased in the United States with direct procurement with machine perfusion (DPP) and thoracoabdominal normothermic regional perfusion (TA-NRP) techniques. There remains a p ...
Full textCite
Journal articleHeart failure reviews · May 2025
Right heart catheterization (RHC) provides critical hemodynamic insights by measuring atrial, ventricular, and pulmonary artery pressures, as well as cardiac output (CO). Although the use of RHC has decreased, its application has been linked to improved ou ...
Full textCite
Journal articleJournal of cardiac failure · May 2025
BackgroundOptimal management of outpatients with heart failure (HF) requires serially updating the estimates of their risk for adverse clinical outcomes to guide treatment. Patient-reported outcomes (PROs) are becoming increasingly used in clinica ...
Full textCite
Preprint · February 15, 2025
Ischemic heart disease and acute myocardial infarction (AMI) is a leading cause of morbidity and mortality. Improvements have been made in coronary interventions to restore blood flow, but ischemia/reperfusion (I/R) injury significantly impacts clinical ou ...
Full textLink to itemCite
Journal articleJournal of the American Heart Association · February 2025
BackgroundMultidisciplinary teams and regionalized care systems have been suggested to improve cardiogenic shock (CS) outcomes. We sought to identify clinical factors associated with successful outcomes for patients developing CS at an outside hea ...
Full textCite
Journal articleCirculation · January 2025
BackgroundCardiomyocytes in the adult human heart show a regenerative capacity, with an annual renewal rate of ≈0.5%. Whether this regenerative capacity of human cardiomyocytes is employed in heart failure has been controversial.MethodsWe ...
Full textCite
Journal articleASAIO journal (American Society for Artificial Internal Organs : 1992) · December 2024
Currently, the fully magnetically levitated left ventricular assist device (LVAD) HeartMate 3 (HM3) is the only commercially available device for advanced heart failure (HF) patients. However, the left ventricular (LV) functional and structural changes fol ...
Full textCite
Journal articleCirculation. Heart failure · November 2024
BackgroundMultidisciplinary Shock Teams have improved clinical outcomes for cardiogenic shock, but their implementation costs have not been studied. This study's objective was to compare costs between patients treated with and without a Shock Team ...
Full textCite
Preprint · October 2, 2024
Text AbstractBackgroundCarnitine palmitoyl transferase 1 (CPT1) is a rate-limiting enzyme for long chain fatty acid oxidation (FAO) i ...
Full textCite
Journal articleCirculation. Heart failure · September 2024
BackgroundCardiogenic shock (CS) mortality remains near 40%. In addition to inadequate cardiac output, patients with severe CS may exhibit vasodilation. We aimed to examine the prevalence and consequences of vasodilation in CS.MethodsWe a ...
Full textCite
Journal articleCirculation. Heart failure · September 2024
BackgroundCardiogenic shock (CS) can stem from multiple causes and portends poor prognosis. Prior studies have focused on acute myocardial infarction-CS; however, acute decompensated heart failure (ADHF)-CS accounts for most cases. We studied pati ...
Full textCite
Journal articleJournal of the American Heart Association · July 2024
BackgroundType 2 diabetes is prevalent in cardiovascular disease and contributes to excess morbidity and mortality. We sought to investigate the effect of glycemia on functional cardiac improvement, morbidity, and mortality in durable left ventric ...
Full textCite
Journal articleClinical transplantation · May 2024
IntroductionSince the 2018 change in the US adult heart allocation policy, more patients are bridged-to-transplant on temporary mechanical circulatory support (tMCS). Previous studies indicate that durable left ventricular assist devices (LVAD) ma ...
Full textCite
Journal articleJournal of clinical medicine · May 2024
Background: Centrifugal-flow left ventricular assist devices (CF-LVADs) have improved morbidity and mortality for their recipients. Hospital readmissions remain common, negatively impacting quality of life and survival. We sought to identify risk fa ...
Full textCite
Preprint · April 20, 2024
Mechanical unloading and circulatory support with left ventricular assist devices (LVADs) mediate significant myocardial improvement in a subset of advanced heart failure (HF) patients. The clinical and biological phenomena associated with cardiac recovery ...
Full textLink to itemCite
Journal articleJournal of the American Medical Informatics Association : JAMIA · April 2024
ObjectivesWe conducted an implementation planning process during the pilot phase of a pragmatic trial, which tests an intervention guided by artificial intelligence (AI) analytics sourced from noninvasive monitoring data in heart failure patients ...
Full textCite
Journal articleJAMA cardiology · March 2024
ImportanceThe existing models predicting right ventricular failure (RVF) after durable left ventricular assist device (LVAD) support might be limited, partly due to lack of external validation, marginal predictive power, and absence of intraoperat ...
Full textCite
Preprint · November 16, 2023
Mitochondrial ion channels are essential for energy production and cell survival. To avoid depleting the electrochemical gradient used for ATP synthesis, channels so far described in the mitochondrial inner membrane open only briefly, are highly ion-select ...
Full textLink to itemCite
Journal articleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · July 2023
By unloading the failing heart, left ventricular (LV) assist devices (LVADs) provide a favorable environment for reversing adverse structural and functional cardiac changes. Prior reports have suggested that an improved native LV function might contribute ...
Full textCite
Journal articleCirculation · January 2023
BackgroundExtensive evidence from single-center studies indicates that a subset of patients with chronic advanced heart failure (HF) undergoing left ventricular assist device (LVAD) support show significantly improved heart function and reverse st ...
Full textCite
Book section · January 1, 2023
Heart failure (HF) is characterized by a pathologic process known as remodeling that involves progressive enlargement of the ventricle, reduction in contractility, and an increase in intracardiac pressures. Patients with chronic advanced HF supported with ...
Full textCite
Journal articleAmerican heart journal plus : cardiology research and practice · October 2022
ObjectiveIn chronic heart failure (HF) patients supported with continuous-flow left ventricular assist device (CF-LVAD), we aimed to assess the clinical association of pre-LVAD QRS duration (QRSd) with post-LVAD cardiac recovery, and its correlati ...
Full textCite
Journal articleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · August 2022Full textCite
Journal articleJournal of clinical medicine · June 2022
Left ventricular assist devices (LVADs) are an established treatment modality for advanced heart failure (HF). It has been shown that through volume and pressure unloading they can lead to significant functional and structural cardiac improvement, allowing ...
Full textCite
Journal articleCirculation. Heart failure · March 2022
BackgroundExtrinsic control of cardiomyocyte metabolism is poorly understood in heart failure (HF). FGF21 (Fibroblast growth factor 21), a hormonal regulator of metabolism produced mainly in the liver and adipose tissue, is a prime candidate for s ...
Full textCite
Journal articleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · December 2021
ObjectiveTo identify predictors of 30-day all-cause mortality for patients with cardiogenic shock secondary to acute coronary syndrome (ACS-CS) who require short-term mechanical circulatory support (ST-MCS).BackgroundACS-CS mortality is h ...
Full textCite
Journal articleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · October 2021
Implantable cardioverter-defibrillators (ICDs) remain the standard of care in advanced heart failure with reduced ejection fraction patients for the prevention of sudden cardiac death. However, current guidelines remain conflicting with respect to the use ...
Full textCite
Journal articleJournal of the American Heart Association · October 2021
Background Recent prospective multicenter data from patients with advanced heart failure demonstrated that left ventricular assist device (LVAD) support combined with standard heart failure medications, induced significant cardiac structural and functional ...
Full textCite
Journal articleNPJ aging and mechanisms of disease · May 2021
It is well established that the aging heart progressively remodels towards a senescent phenotype, but alterations of cellular microstructure and their differences to chronic heart failure (HF) associated remodeling remain ill-defined. Here, we show that th ...
Full textCite
Journal articleCirculation. Heart failure · May 2021
BackgroundVariable definitions and an incomplete understanding of the gradient of reverse cardiac remodeling following continuous flow left ventricular assist device (LVAD) implantation has limited the field of myocardial plasticity. We evaluated ...
Full textCite
Journal articleFrontiers in physiology · January 2021
With an estimated 64.3 million cases worldwide, heart failure (HF) imposes an enormous burden on healthcare systems. Sudden death from arrhythmia is the major cause of mortality in HF patients. Computational modeling of the failing heart provides insights ...
Full textCite